tradingkey.logo
tradingkey.logo
Search

Medtronic PLC

MDT
Add to Watchlist
82.350USD
-0.940-1.13%
Close 07/21, 16:00ETQuotes delayed by 15 min
105.69BMarket Cap
22.89P/E TTM

More Details of Medtronic PLC Company

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Medtronic PLC Info

Ticker SymbolMDT
Company nameMedtronic PLC
IPO dateNov 21, 1977
CEOMartha (Geoffrey S)
Number of employees95000
Security typeOrdinary Share
Fiscal year-endNov 21
AddressBuilding Two Parkmore Business Park West
CityDUBLIN
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryIreland
Postal codeH91 4K49
Phone1135314381700
Websitehttps://www.medtronic.com/
Ticker SymbolMDT
IPO dateNov 21, 1977
CEOMartha (Geoffrey S)

Company Executives of Medtronic PLC

Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
23.61K
+8.06%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
19.54K
+9.74%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
10.10K
+18.86%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Independent Director
Independent Director
7.63K
+24.97%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%

FAQs

Who are the top five shareholders of Medtronic PLC?

The top five shareholders of Medtronic PLC are: Mr. Geoffrey S. (Geoff) Martha

How many institutions hold shares of Medtronic PLC (MDT)?

As of 2026Q1, 3854 institutions hold shares of Medtronic PLC, with a combined market value of approximately 1.12B, accounting for 86.90% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -35115160.00.

What is the biggest source of revenue for Medtronic PLC?

In 2026Q1, the Cardiac Rhythm & Heart Failure business generated the highest revenue for Medtronic PLC, amounting to 1.86B and accounting for 20.58% of total revenue.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.